Colorado Coagulation, Laboratory Corporation of America® Holdings, Englewood, Colorado.
Am J Hematol. 2014 Jul;89(7):781-4. doi: 10.1002/ajh.23723. Epub 2014 Apr 15.
Factor VIII (FVIII) may be measured by three different methodologies in the clinical laboratory: one-stage clotting assay, two-stage clotting assay, and chromogenic assay. These assays differ in ease of use, variety of reagents available, sensitivity to mild hemophilia A, and interference from lupus anticoagulants. This review will outline the methodology for each of the FVIII activity assays, with a discussion of assay interferences and variability. In some cases, chromogenic FVIII activity assays may be preferable to clot-based assays, and these clinical situations will be reviewed as well.
VIII 因子(FVIII)在临床实验室中可以通过三种不同的方法进行测量:一步法凝血测定、两步法凝血测定和显色测定。这些测定方法在易用性、可用试剂的种类、对轻度血友病 A 的敏感性以及狼疮抗凝物的干扰方面有所不同。本综述将概述每种 FVIII 活性测定方法的方法学,并讨论测定干扰和变异性。在某些情况下,显色 FVIII 活性测定可能优于基于凝血的测定,这些临床情况也将进行回顾。